Thursday, March 9th Agenda
9:30AM ET
VolitionRX Ltd.

NYSE American: VNRX
Industry: Epigenetics - Cancer
Scott Powell, Head of Investor Relations & U.S. Chief Financial Officer

10:00AM ET
Synlogic, Inc.

Nasdaq: SYBX
Industry: Synthetic Biotics
Michael Jensen, CFO

10:30AM ET
Lisata Therapeutics, Inc.

NASDAQ: LSTA
Biopharma - Cellular Therapies
David Mazzo, CEO

11:00AM ET
InMed Pharmaceuticals Inc.

NASDAQ: INM
Pharmaceutical - Cannabinoids
Eric Adams, President & CEO

11:30AM ET
Valeo Pharma Inc

OTCQB: VPHIF | TSX: VPH
Pharmaceutical - Respirology, Neurodegenerative Diseases, and Oncology
Steve Saviuk, CEO

12:00PM ET
Roquefort Therapeutics plc

OTCQB: ROQAF | LSE: ROQ
Biotech - Cancer treatment
Ajan Reginald, CEO

{"@context": "https://schema.org","@type": "Event","name": "Life Science Investor Forum","startDate": "2023-03-09T10:00:00-05:00","eventAttendanceMode": "OnlineEventAttendanceMode","image": ["https://otcmarkets.gcs-web.com/static-files/437fc1c3-ca26-4d39-a781-a357d5847908","https://otcmarkets.gcs-web.com/static-files/3db571b2-b29d-4d02-876f-72d71238ae2f","https://otcmarkets.gcs-web.com/static-files/782beb53-55a6-4811-adff-7757e116f0f4"],"location":{"@type": "VirtualLocation","url": "https://www.virtualinvestorconferences.com/events/event-details/life-science-investor-forum"},"description": "Virtual Investor Conferences combine leading-edge online conferencing and investor communications capabilities with a comprehensive global investor audience network."}